Aurora Cannabis receives Health Canada Licensing

The licensing will be held by Aurora Sky and MedReleaf Bradford

Aurora Cannabis (TSE: ACB) announced yesterday that two of its facilities have received full licenses from Health Canada. The facilities are Aurora Sky and MedReleaf Bradford, and both are now authorized for the production and sale of cannabis and cannabis-derived products.

Aurora Sky is located at the Edmonton International Airport in Alberta. It was the company’s first “Sky Class” facility and is designed to provide “high quality, consistent and highly cost-efficient” cannabis cultivation. The facility covers 800,000 square feet and uses state-of-the-art technology with a great deal of automation to deliver target productions costs that are under $1 per gram. The facility is expected to be fully planted next month following the license approval.

MedReleaf’s facility expands across 210,000 square feet in Ontario. It is also a high-tech production facility and features 17 independently climate-controlled grow rooms. It is able to handle large-scale, hang-dried production and 13 of the flower rooms are currently in production for both consumer and medical markets. The facility will be fully planted by early April and can produce up to 28,000kg of cannabis per year.

Aurora CEO Terry Booth explains, “The rapid scale-up of our production capacity – with our Sky and Bradford facilities specifically adding over 128,000 kg per year in capacity – is resulting in significant increases in product availability across our domestic medical and consumer, as well as our international market segments, over the coming months. Current production at Aurora Sky, with recent harvests exceeding target yields, validates our production philosophy and our investment in high-tech, highly automated facilities. MedReleaf Bradford employs best practices identified during the integration of the Aurora and MedReleaf organizations, and is consistently delivering exceptional yields and high-quality product that has resonated well in both the medical and consumer markets.”

Aurora has an overall capacity of more than 500,000kg each year and has operations in 23 countries on five continents. It is involved in many segments of the cannabis chain, from facility engineering and design to cultivation and genetics research. It also manages the production of hemp and cannabis, as well as related derivative, and engages in wholesale and retail distribution.